Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Necroptosis contributes to airborne particulate matter-induced ocular surface injury. | Toxicology | 2022 | 35247514 | PubTator, text mining | PubMed |
| Exploring the glycosylation of mucins by use of O-glycodomain reporters recombinantly expressed in glycoengineered HEK293 cells. | J Biol Chem | 2022 | 35247390 | PubTator, text mining | PubMed |
| When is a lipoma not a lipoma? Case report presenting a lipoblastoma-like tumor of the gluteal cleft in an older gentleman with literature review. | Int J Surg Case Rep | 2022 | 35245849 | PubTator, text mining | PubMed |
| Tertiary lymphoid structure and decreased CD8+ T cell infiltration in minimally invasive adenocarcinoma. | iScience | 2022 | 35243243 | PubTator, text mining | PubMed |
| A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection. | Transl Lung Cancer Res | 2022 | 35242625 | PubTator, text mining | PubMed |
| Identification and Quantification of Necroptosis Landscape on Therapy and Prognosis in Kidney Renal Clear Cell Carcinoma. | Front Genet | 2022 | 35237304 | PubTator, text mining | PubMed |
| Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis. | Cell Mol Biol Lett | 2022 | 35236304 | PubTator, text mining | PubMed |
| System-wide transcriptome damage and tissue identity loss in COVID-19 patients. | Cell Rep Med | 2022 | 35233546 | PubTator, text mining | PubMed |
| Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer. | J Clin Lab Anal | 2022 | 35229919 | PubTator, text mining | PubMed |
| A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors. | HGG Adv | 2022 | 35224516 | PubTator, text mining | PubMed |
| Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review. | Eur Urol | 2022 | 35216855 | PubTator, text mining | PubMed |
| MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets. | Int J Mol Sci | 2022 | 35216281 | PubTator, text mining | PubMed |
| Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review. | Int J Mol Sci | 2022 | 35216204 | PubTator, text mining | PubMed |
| Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens? | Int J Mol Sci | 2022 | 35216137 | PubTator, text mining | PubMed |
| Transmembrane Mucin 1 Blocks Fluorescein Ingress to Corneal Epithelium. | Invest Ophthalmol Vis Sci | 2022 | 35212722 | PubTator, text mining | PubMed |
| Primary orbital monophasic synovial sarcoma with calcification: A case report. | World J Clin Cases | 2022 | 35211602 | PubTator, text mining | PubMed |
| Giant nodular fasciitis originating from the humeral periosteum: A case report. | World J Clin Cases | 2022 | 35211594 | PubTator, text mining | PubMed |
| Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways. | Life (Basel) | 2022 | 35207462 | PubTator, text mining | PubMed |
| Prognostic and Predictive Molecular Markers in Cholangiocarcinoma. | Cancers (Basel) | 2022 | 35205774 | PubTator, text mining | PubMed |
| Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome. | Cancers (Basel) | 2022 | 35205758 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=57